Related Experiment Video
Updated: May 22, 2026

03:57
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Glucose intolerance and primary hyperparathyroidism: an unresolved relationship
Endocrine
|April 26, 2012
Summary
Normocalcemic primary hyperparathyroidism (PHPT) may not be linked to insulin resistance or glucose intolerance. Further research with rigorously classified patients is needed to confirm this finding in normocalcemic PHPT.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Calcium Homeostasis
Background:
- Primary hyperparathyroidism (PHPT) presents as symptomatic, asymptomatic, or normocalcemic. Recent studies explore the metabolic implications of normocalcemic PHPT.
- Insulin resistance and glucose intolerance are potential comorbidities investigated in various PHPT classifications.
Discussion:
- The current study by Cakir et al. suggests no association between normocalcemic PHPT and glucose intolerance.
- However, the classification of normocalcemic PHPT subjects in existing literature, including the current study, lacks rigor.
- This heterogeneity complicates definitive conclusions regarding metabolic disturbances in normocalcemic PHPT.
Key Insights:
- Normocalcemic PHPT may not be associated with insulin resistance or glucose intolerance.
- Inconsistent subject classification hinders accurate assessment of metabolic comorbidities in normocalcemic PHPT.
- The study highlights the need for standardized criteria in characterizing normocalcemic PHPT.
Outlook:
- Future research must focus on rigorously defined cohorts to accurately determine the presence of glucose intolerance in normocalcemic PHPT.
- Standardized phenotyping of normocalcemic PHPT is crucial for understanding its metabolic profile.
- Clarifying the relationship between normocalcemic PHPT and metabolic health will inform clinical management.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

